ritanserin has been researched along with thromboxane b2 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Blöchl-Daum, B; Brenner, B; Eichler, HG; Kyrle, PA; Lechner, K; Schneider, B; Speiser, W; Wagner, B | 1 |
1 trial(s) available for ritanserin and thromboxane b2
Article | Year |
---|---|
Effect of ritanserin, a 5-hydroxytryptamine2-receptor antagonist, on platelet function and thrombin generation at the site of plug formation in vivo.
Topics: Adult; beta-Thromboglobulin; Bleeding Time; Blood Platelets; Double-Blind Method; Fibrinopeptide A; Humans; Piperidines; Platelet Aggregation; Platelet Aggregation Inhibitors; Ritanserin; Serotonin Antagonists; Thrombin; Thromboxane B2 | 1990 |